Company Name: Affimed N.V.

Affimed N.V. is a clinical stage biopharmaceutical company. The company is engaged in the development of targeted immunotherapies for the treatment of cancer.

Ticker Symbol: AFMD (NASDAQ)

Company Website: www.affimed.com

Social Media: Affimed LinkedIn

Headquarters: Heidelberg, Germany